Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfiler

NCT01463410 is registered in ClinicalTrials.gov with Skyline Diagnostics BV as lead sponsor.

NCT NCT01463410
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01463410 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfiler
Lead sponsor
Skyline Diagnostics BV
Phase
Observational
Overall status
Terminated
Start date
October 31, 2011
Completion date
March 31, 2013
Enrollment
264 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia (aml), acute promyelocytic leukemia (apl), refractory anemia with excess of blasts (raeb)